Aardvark Therapeutics, Inc. Common Stock

AARD

NASDAQ

$ -

Review earnings summary, surprise history, and upcoming forecasts.

account_balance_walletEarnings Summary

Updated: 05/07/2026FY2026 Q1

Revenue (TTM)

0M USD

YoY -

Net Income (TTM)

-22M USD

YoY Expanded Deficit

Equity Ratio

88.2%

YoY -7.7pt

BPS

3.99$

YoY -42.6%

Revenue

FY2024 Q2$0

FY2024 Q3$0

FY2024 Q4$0

FY2025 Q1$0

FY2025 Q2$0

FY2025 Q3$0

FY2025 Q4$0

FY2026 Q1$0

Actual

YoY$0 (-)

Net Income

$-21.6M

FY2024 Q2$-7.6M

$-7.6M

FY2024 Q3$-11.8M

$-11.8M

Surprise History

Actual RevenueAnalyst Estimate

FY2022

Actual:$0

FY2022

FY2023